Matrix metalloproteinase inhibitors and cancer

Expert Opinion on Therapeutic Patents

Volumn 10, Issue 12, 2000, Pages 1873-1884

  Lauer Fields, J L ^a   Fields, G B ^a  

^a FLORIDA ATLANTIC UNIVERSITY   (United States)

Author keywords

Cancer; Enzyme inhibitors; Hydroxamic acids; Matrix metalloproteinases; Therapeutics

Indexed keywords

COLLAGEN DERIVATIVE; COLLAGEN TYPE 4; COLLAGEN TYPE 5; COLLAGENASE; COLLAGENASE 3; ENZYME PRECURSOR; GELATIN; GELATINASE A; GELATINASE B; HEMOPEXIN; HYDROXAMIC ACID DERIVATIVE; LEUKOCYTE ELASTASE; MACROPHAGE ELASTASE; MARIMASTAT; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 15; MATRIX METALLOPROTEINASE 16; MATRIX METALLOPROTEINASE INHIBITOR; NEUTROPHIL COLLAGENASE; POLYPEPTIDE; SCLEROPROTEIN; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; STROMELYSIN; STROMELYSIN 2; STROMELYSIN 3; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITRONECTIN;

ARTICLE; CANCER INVASION; CANCER RESEARCH; CELL INVASION; CONNECTIVE TISSUE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG RESEARCH; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME METABOLISM; EXTRACELLULAR MATRIX; HUMAN; METASTASIS; PATENT; PROTEIN FAMILY; REVIEW; TENDINITIS; TUMOR CELL;

EID: 0033665199     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.10.12.1873     Document Type: Article

References (46)

1. Cancer cell invasion and metastasis
2. Matrix metalloproteinases and tumor invasion: From correlation and causality to the clinic
3. Matrix metalloptoteinases as stromal effectors of human carcinoma progression: Therapeutic implications
4. Changing views of the role of matrix metalloproteinases in metastasis
5. Matrix metalloproteinases and metastasis
6. Matrix metalloproteinases: Biologic activity and clinical implications
7. Remodeling MMPIs
8. Recent advances in matrix metalloproteinase inhibitor research
9. Matrix metalloproteinase inhibition as a novel anticancer strategy: A review with special focus on batimastat and marimastat
10. Structural properties of matrix metalloproteinases
11. Recent advances in the field of matrix metalloproteinase inhibitors
12. Matrix metalloproteinase inhibitors 1998
13. Matrix metalloproteinases
14. Matrix metalloproteinases
15. Human matrix metalloproteinase specificity studies using collagen sequence-based synthetic peptides
16. Membrane associated matrix metalloproteinases in metastasis
17. Structure of the catalytic domain of human fibroblast collagenase complexed with an inhibitor
18. 1.56 A Structure of mature truncated human fibroblast collagenase
19. Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed β-propeller
20. Solution structure of the catalytic domain of human stromelysin complexed with a hydrophobic inhibitor
21. X-ray structure of human stromelysin catalytic domain complexed with nonpeptide inhibitors: Implications for inhibitor selectivity
22. The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity
23. Structure of human neutrophil collagenase reveals large S1' specificity pocket
24. Structure determination and analysis of human neutrophil collagenase complexed with a hydroxamate inhibitor
25. Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor
26. Comparison of the structure of human recombinant short form stromelysin by multidimensional heteronuclear NMR and X-ray crystallography
27. Assignments, secondary structure and dynamics of the inhibitor-free catalytic fragment of human fibroblast collagenase
28. Insights into MMP-TIMP interactions
29. Structure of human pro-matrix metalloproteinase-2: Activation mechanism revealed
30. Crystal structure of an ecotin-collagenase complex suggests a model for recognition and cleavage of the collagen triple helix
31. 1.7 A X-ray structure of space-grown collagenase crystals
32. European roundup: No anticancer benefit in trials of marimastat
33. European roundup: Andre Pernet assumes the helm at Genset
34. Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis
35. Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: A structure-activity study
36. Potent and selective mechanism-based inhibition of gelatinases
37. Identification of highly selective inhibitors of collagenase-1 from combinatorial libraries of diketopiperazines
38. Matrix metalloproteinase inhibition by green tea catchins
39. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1
40. Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells
41. Basement membrane Type IV collagen degradation: Evidence for the involvement of proteolytic cascade independent of matrix metalloproteinases
42. Design and synthesis of heterotrimetric collagen peptides with a built-in cystine-knot
43. Disulfide-bridged heterotrimeric collagen peptides containing the collagenase cleavage site of collagen Type I: Synthesis and conformational properties
44. Recognition and catabolism of synthetic heterotrimeric collagen peptides by matrix metalloproteinases
45. Hydrolysis of triple-helical collagen peptide models by matrix metalloproteinases
46. Use of Edman degradation sequence analysis and matrix-assisted laser desorption/ionization mass spectrometry in designing substrates for matrix metalloproteinases